taxoids - CISMeF

Preferred Label : taxoids;

MeSH definition : A group of diterpenoid CYCLODECANES named for the taxanes that were discovered in the TAXUS tree. The action on MICROTUBULES has made some of them useful as ANTINEOPLASTIC AGENTS.;

MeSH synonym : Taxoid;

MeSH hyponym : taxanes;

MeSH annotation : ROTAXANES is also available;

Wikipedia link : https://en.wikipedia.org/wiki/Taxoids;

Is substance : O;

Details

Origin ID

D043823;

UMLS CUI

C1257832;

ATC code(s)
- taxanes [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Taxane Compound [NCIt concept]
- Taxanes [ICD-11 Extension code]
- taxanes [ATC Code]
Indexing information
- CSAG2 protein, human [MeSH Supplementary Concept]
- CYP2C8 protein, human [MeSH Supplementary Concept]
- benzoyl-coenzyme A taxane 2-O-benzoyltransferase [MeSH Supplementary Concept]
Record concept(s)
- taxanes [MeSH concept]
- taxoids [MeSH concept]
Related MeSH Supplementary Concept(s)
- ((azidophenyl)ureido)taxoid [MeSH Supplementary Concept]
- (2alpha,5alpha,7beta,9alpha,10beta,13alpha)-5,10,13,20-tetraacetoxytax-11-ene-2,7,9-triol [MeSH Supplementary Concept]
- (2alpha,5alpha,9alpha,10beta)-2,9,10-triacetoxy-5-((beta-D-glucopyranosyl)oxy)-3,11-cyclotax-11-en-13-one [MeSH Supplementary Concept]
- 1,7-dihydroxytaxinine [MeSH Supplementary Concept]
- 1-acety-5,7,10-deacetyl-baccatin I [MeSH Supplementary Concept]
- 1-dehydroxybaccatin VI [MeSH Supplementary Concept]
- 1-deoxybaccatin VI [MeSH Supplementary Concept]
- 1-hydroxy- 2-deacetoxy-5-decinnamoyl-taxinine j [MeSH Supplementary Concept]
- 1-hydroxy-7,9-dideacetylbaccatin I [MeSH Supplementary Concept]
- 1-hydroxybaccatin I [MeSH Supplementary Concept]
- 10-Deacetyl baccatin III dimethyl sulfoxide disolvate [MeSH Supplementary Concept]
- 10-O-acetyl-2-O-(cyclohexylcarbonyl)-2-debenzoyltaxotere [MeSH Supplementary Concept]
- 10-O-sec-aminoethyl docetaxel [MeSH Supplementary Concept]
- 10-acetyl-4-deacetyltaxotere [MeSH Supplementary Concept]
- 10-deacetoxypaclitaxel [MeSH Supplementary Concept]
- 10-deacetyl-10-(3-aminobenzoyl)paclitaxel [MeSH Supplementary Concept]
- 10-deacetyl-10-(7-(diethylamino)coumarin-3-carbonyl)paclitaxel [MeSH Supplementary Concept]
- 10-deacetyl-9-dihydrotaxol [MeSH Supplementary Concept]
- 10-deacetylbaccatine III [MeSH Supplementary Concept]
- 10-deacetylpaclitaxel [MeSH Supplementary Concept]
- 10-deacetyltaxinine [MeSH Supplementary Concept]
- 10-deacetyltaxol [MeSH Supplementary Concept]
- 10-deoxy-10-C-morpholinoethyl docetaxel [MeSH Supplementary Concept]
- 10alpha,18-epoxy-10beta-hydroxy-9-oxo-2alpha,5alpha,14beta-triacetoxytaxa-4(20),11(12)-diene [MeSH Supplementary Concept]
- 10beta-acetoxy-5alpha-((3'-dimethylamino-3'-phenyl)-propionyloxy)moiety-9alpha-hydroxy-taxa-4(20)11-dien-13-one [MeSH Supplementary Concept]
- 11-desmethyllaulimalide [MeSH Supplementary Concept]
- 13-(N-tert-butoxycarbonyl-3-isobutylisoserinoyl-4,10-diacetoxy-2-benzoyloxy-5-20-epoxy-1,13-dihydroxy-9-oxo-19-norcyclopropa(g)tax-11-ene [MeSH Supplementary Concept]
- 13-deoxo-13-acetyloxy-7,9-diacetyl-1,2-dideoxytaxine [MeSH Supplementary Concept]
- 13-deoxybaccatin III [MeSH Supplementary Concept]
- 14-hydroxy-10-deacetyl-2-O-debenzoylbacatin III [MeSH Supplementary Concept]
- 14-hydroxy-10-deacetylbaccatin III [MeSH Supplementary Concept]
- 14beta-benzoyloxy-13-deacetylbaccatin IV [MeSH Supplementary Concept]
- 14beta-benzoyloxy-2-deacetylbaccatin VI [MeSH Supplementary Concept]
- 14beta-benzoyloxybaccatin IV [MeSH Supplementary Concept]
- 19-hydroxybaccatin III [MeSH Supplementary Concept]
- 2',2''-methylenedocetaxel [MeSH Supplementary Concept]
- 2',2''-methylenepaclitaxel [MeSH Supplementary Concept]
- 2'-(2-bromohexadecanoyl)docetaxel [MeSH Supplementary Concept]
- 2'-(valyl-leucyl-lysyl-PABC)paclitaxel [MeSH Supplementary Concept]
- 2'-O-acetyl-7-O-(N-(4'-fluoresceincarbonyl)alanyl)taxol [MeSH Supplementary Concept]
- 2'-acetyltaxol [MeSH Supplementary Concept]
- 2,10,13-triacetoxy-taxa-4(20),11-diene-5,7,9-triol [MeSH Supplementary Concept]
- 2,10-diacetyl-5(Z)-cinnamoylphototaxicin II [MeSH Supplementary Concept]
- 2,20-O-diacetyltaxumairol N [MeSH Supplementary Concept]
- 2-(4-azidobenzoyl)taxol [MeSH Supplementary Concept]
- 2-O-(cyclohexylcarbonyl)-2-debenzoylbaccatin III 13-O-(N-(cyclohexylcarbonyl)-3-cyclohexylisoserinate) [MeSH Supplementary Concept]
- 2-deacetoxy-7beta,9a,10beta-trideacetyltaxinine J [MeSH Supplementary Concept]
- 2-deacetoxytaxinine J [MeSH Supplementary Concept]
- 2-debenzoyl-2-m-methoxybenozyl-7-triethylsilyl-13-oxo-14-hydroxybaccatin III 1,14-carbonate [MeSH Supplementary Concept]
- 2alpha, 7beta, 9alpha, 10beta, 13alpha-pentaacetoxyltaxa-4 (20) , 11-dien-5-ol [MeSH Supplementary Concept]
- 2alpha,5alpha,7beta,9alpha,13alpha-pentahydroxy-10beta-acetoxytaxa-4(20),11-diene [MeSH Supplementary Concept]
- 2alpha,7beta,10beta-triacetoxy-5-cinnamyloxy-9alpha-hydroxy-3alpha,11alpha-cyclotaxa-4(20),5-dien-13-one [MeSH Supplementary Concept]
- 2alpha,7beta,9alpha,10beta,13-pentaacetoxy-11beta-hydroxy-5alpha-(3'-N,N-dimethylamino-3'-phenyl)-propionyloxytaxa-4(20),12-diene [MeSH Supplementary Concept]
- 2alpha,7beta-diacetoxy-5alpha,10beta,13beta-trihydroxy-2(3-20)abeotaxa-4(20),11-dien-9-one [MeSH Supplementary Concept]
- 2alpha,9alpha,10beta-triacetoxy-13alpha(beta-D-glucopyranosyloxy)taxa-4(20),11-dien-5alpha-ol [MeSH Supplementary Concept]
- 2alpha,9alpha-dihydroxy-10beta,13alpha-diacetoxy-5alpha-(3'-methylamino-3'-phenyl)-propionyloxytaxa-4(20),11-diene [MeSH Supplementary Concept]
- 2alpha-hydroxy-7beta,9alpha,10beta,13alpha-tetraacetoxy-5alpha-(2'-hydroxy-3'-N,N-dimethylamino-3'-phenyl)-propionyloxytaxa-4(20),11-diene [MeSH Supplementary Concept]
- 3'-(4-azidobenzamido)taxol [MeSH Supplementary Concept]
- 3'-N-(4-benzoyldihydrocinnamoyl)-3'-N-debenzoylpaclitaxel [MeSH Supplementary Concept]
- 3'-N-m-aminobenzamido-3'-debenzamidopaclitaxel [MeSH Supplementary Concept]
- 3'-p-hydroxypaclitaxel [MeSH Supplementary Concept]
- 3,11-cyclotaxinine NN-2 [MeSH Supplementary Concept]
- 4-deacetyl-1-dimethylsilyl-7-triethylsilylbaccatin III [MeSH Supplementary Concept]
- 4-deacetylbaccatin III [MeSH Supplementary Concept]
- 4-deacetyltaxol [MeSH Supplementary Concept]
- 5(12)-oxa-3(11)-cyclotaxane [MeSH Supplementary Concept]
- 5,13 -diacetoxy-taxa-4(20),11-diene-9,10-diol [MeSH Supplementary Concept]
- 5-O-benzoylated taxinine K [MeSH Supplementary Concept]
- 5-O-phenylpropionyloxytaxinine A [MeSH Supplementary Concept]
- 5a-acetoxy-20-(benzoyloxy)-2a,4a,7b,9a,15-pentahydroxy-10- oxo-10,19-epoxy-11(15-1)abeo-tax-11(12)-ene [MeSH Supplementary Concept]
- 5alpha,10beta,13alpha-triacetoxytax-11-ene-2alpha,7beta,9alpha,20-tetraol [MeSH Supplementary Concept]
- 5alpha,10beta,13beta-triacetoxy-2 alpha,7beta-dihydroxy-2(3-20) abeotaxa-4(20),11-dien-9-one [MeSH Supplementary Concept]
- 5alpha,13alpha-diacetoxy-10beta-cinnamoyloxy-4(20),11-taxadien-9alpha-ol [MeSH Supplementary Concept]
- 6,3'-p-dihydroxypaclitaxel [MeSH Supplementary Concept]
- 6-alpha-hydroxy-7-deoxy-10-deacetylbaccatin-III [MeSH Supplementary Concept]
- 6-fluoro-10-acetyldocetaxel [MeSH Supplementary Concept]
- 6-hydroxytaxol [MeSH Supplementary Concept]
- 7'-epidocetaxel [MeSH Supplementary Concept]
- 7,10-bis-O-(2,2,2-trichloroethoxycarbonyl)-10-deacetyl baccatin III-ethyl acetate [MeSH Supplementary Concept]
- 7,13-diacetoxy-5-cinnamyloxy-2(3-20)-abeo-taxa-4(20),11-diene-2,10-diol [MeSH Supplementary Concept]
- 7,13-dideacetyl-2,9,10-debenzoyl-2-tigloyl-7beta,9alpha-p-hydroxylbenzylidenedioxy-taxchinin C [MeSH Supplementary Concept]
- 7,13-dideacetyl-9,10-debenzoyl-7beta,9alpha-p-hydroxylbenzylidenedioxy-taxchinin C [MeSH Supplementary Concept]
- 7,9-dideacetylbaccatin VI [MeSH Supplementary Concept]
- 7-(5'-Biotinylamidopropanoyl)paclitaxel [MeSH Supplementary Concept]
- 7-O-(4-benzoyldihydrocinnamoyl)paclitaxel [MeSH Supplementary Concept]
- 7-O-(N-(4'-fluoresceincarbonyl)alanyl)taxol [MeSH Supplementary Concept]
- 7-acetyltaxol [MeSH Supplementary Concept]
- 7-deoxy-10-deacetylbaccatin-III [MeSH Supplementary Concept]
- 7-deoxy-9-dihydropaclitaxel [MeSH Supplementary Concept]
- 7-epipaclitaxel [MeSH Supplementary Concept]
- 7-methylthiomethylpaclitaxel [MeSH Supplementary Concept]
- 7-xylosyl-10-deacetyltaxol [MeSH Supplementary Concept]
- 7beta,10beta-diacetoxy-9alpha-hydroxy-3alpha,11alpha-cyclotaxa-4(20),5-dien-13-one [MeSH Supplementary Concept]
- 8,9-single-epoxy brevifolin [MeSH Supplementary Concept]
- 9-dihydrobaccatin III [MeSH Supplementary Concept]
- 9-dihydrotaxol [MeSH Supplementary Concept]
- 9alpha-hydroxy-2alpha,10beta,13alpha-triacetoxy-5alpha-(3'-N,N-dimethylamino-3'-phenyl)-propionyloxytaxa-4(20),11-diene [MeSH Supplementary Concept]
- BAY59 [MeSH Supplementary Concept]
- BMS 181339 [MeSH Supplementary Concept]
- BMS 185660 [MeSH Supplementary Concept]
- BMS188797 [MeSH Supplementary Concept]
- C,D-spirodioxene taxoid [MeSH Supplementary Concept]
- CPT protocol [MeSH Supplementary Concept]
- CTEC protocol [MeSH Supplementary Concept]
- DF protocol [MeSH Supplementary Concept]
- EDP protocol [MeSH Supplementary Concept]
- GET protocol [MeSH Supplementary Concept]
- IDN 5109 [MeSH Supplementary Concept]
- IDN 5111 [MeSH Supplementary Concept]
- IDN 5127 [MeSH Supplementary Concept]
- IDN 5390 [MeSH Supplementary Concept]
- MINT protocol [MeSH Supplementary Concept]
- MST 997 [MeSH Supplementary Concept]
- N-(paclitaxel-2'-O-(2-amino)phenylpropionate)-O-(beta-glucuronyl)carbamate [MeSH Supplementary Concept]
- N-(paclitaxel-2'-O-3,3-dimethyl butanoate)-O-(beta-glucuronyl)carbamate [MeSH Supplementary Concept]
- N-debenzoyl-N-(3-(dimethylamino)benzoyl)paclitaxel [MeSH Supplementary Concept]
- NC-6301 [MeSH Supplementary Concept]
- NPB304 taxane [MeSH Supplementary Concept]
- PET protocol [MeSH Supplementary Concept]
- PNU 166945 [MeSH Supplementary Concept]
- PVC protocol [MeSH Supplementary Concept]
- RPR 109881A [MeSH Supplementary Concept]
- SB T-101187 [MeSH Supplementary Concept]
- SB T-1102 [MeSH Supplementary Concept]
- SB T-1213 [MeSH Supplementary Concept]
- SB T-1214 [MeSH Supplementary Concept]
- SB T-1250 [MeSH Supplementary Concept]
- SB T-12843 [MeSH Supplementary Concept]
- SB-RA-2001 [MeSH Supplementary Concept]
- SB-T-121205 [MeSH Supplementary Concept]
- SID530 [MeSH Supplementary Concept]
- Syl611 compound [MeSH Supplementary Concept]
- TAC protocol [MeSH Supplementary Concept]
- TEC protocol [MeSH Supplementary Concept]
- TIC protocol [MeSH Supplementary Concept]
- TIP regimen [MeSH Supplementary Concept]
- TNT protocol [MeSH Supplementary Concept]
- TP protocol [MeSH Supplementary Concept]
- TPF protocol [MeSH Supplementary Concept]
- TPFL4 regimen [MeSH Supplementary Concept]
- TPFL5 protocol [MeSH Supplementary Concept]
- TPI-287 [MeSH Supplementary Concept]
- XRP6258 [MeSH Supplementary Concept]
- baccatin III [MeSH Supplementary Concept]
- baccatin III 13-O-(N-benzoyl-3-cyclohexylisoserinate) [MeSH Supplementary Concept]
- benzoyltaxol [MeSH Supplementary Concept]
- brevifoliol [MeSH Supplementary Concept]
- butitaxel [MeSH Supplementary Concept]
- cabazitaxel [MeSH Supplementary Concept]
- cephalomannine [MeSH Supplementary Concept]
- dantaxusin A [MeSH Supplementary Concept]
- dantaxusin B [MeSH Supplementary Concept]
- dantaxusin C [MeSH Supplementary Concept]
- dantaxusin D [MeSH Supplementary Concept]
- dibromo-10-deacetylcephalomannine [MeSH Supplementary Concept]
- felotaxel [MeSH Supplementary Concept]
- flutax 2 [MeSH Supplementary Concept]
- glutarylpaclitaxel 6-aminohexanol glucuronide [MeSH Supplementary Concept]
- isolaulimalide [MeSH Supplementary Concept]
- larotaxel [MeSH Supplementary Concept]
- neolaulimalide [MeSH Supplementary Concept]
- nonataxel [MeSH Supplementary Concept]
- octreotide-conjugated paclitaxel [MeSH Supplementary Concept]
- opTPFL regimen [MeSH Supplementary Concept]
- paclitaxel-transferrin [MeSH Supplementary Concept]
- poly(ethylene glycol)-conjugated paclitaxel-2'-glycinate [MeSH Supplementary Concept]
- protax [MeSH Supplementary Concept]
- protaxel [MeSH Supplementary Concept]
- tRA-96023 [MeSH Supplementary Concept]
- tasumatrol B [MeSH Supplementary Concept]
- tasumatrol E [MeSH Supplementary Concept]
- tasumatrol F [MeSH Supplementary Concept]
- tasumatrol G [MeSH Supplementary Concept]
- taxa-4(20),11(12)-dien-5-yl acetate [MeSH Supplementary Concept]
- taxa-4(20),11(12)-diene-5-ol [MeSH Supplementary Concept]
- taxacin [MeSH Supplementary Concept]
- taxane [MeSH Supplementary Concept]
- taxawallin I [MeSH Supplementary Concept]
- taxchinin A [MeSH Supplementary Concept]
- taxchinin N [MeSH Supplementary Concept]
- taxcultine [MeSH Supplementary Concept]
- taxezopidine M [MeSH Supplementary Concept]
- taxezopidine N [MeSH Supplementary Concept]
- taxine [MeSH Supplementary Concept]
- taxinine [MeSH Supplementary Concept]
- taxinine A [MeSH Supplementary Concept]
- taxinine M [MeSH Supplementary Concept]
- taxinine NN-1 [MeSH Supplementary Concept]
- taxinine NN-7 [MeSH Supplementary Concept]
- taxol C-7-xylose [MeSH Supplementary Concept]
- taxol-sialyl conjugate [MeSH Supplementary Concept]
- taxumairol A [MeSH Supplementary Concept]
- taxumairol B [MeSH Supplementary Concept]
- taxumairol G [MeSH Supplementary Concept]
- taxumairol H [MeSH Supplementary Concept]
- taxumairol I [MeSH Supplementary Concept]
- taxumairol K [MeSH Supplementary Concept]
- taxumairol M [MeSH Supplementary Concept]
- taxumairol N [MeSH Supplementary Concept]
- taxumairol O [MeSH Supplementary Concept]
- taxumairol U [MeSH Supplementary Concept]
- taxumairol V [MeSH Supplementary Concept]
- taxumairol W [MeSH Supplementary Concept]
- taxumairol-X [MeSH Supplementary Concept]
- taxumairol-Y [MeSH Supplementary Concept]
- taxumairol-Z [MeSH Supplementary Concept]
- taxusecone [MeSH Supplementary Concept]
- taxusin [MeSH Supplementary Concept]
- taxuspinanane A [MeSH Supplementary Concept]
- taxuspinanane B [MeSH Supplementary Concept]
- taxuspine C [MeSH Supplementary Concept]
- taxuspine D [MeSH Supplementary Concept]
- taxuspine F [MeSH Supplementary Concept]
- taxuyunnanine C [MeSH Supplementary Concept]
- taxuyunnanine S [MeSH Supplementary Concept]
- taxuyunnanine T [MeSH Supplementary Concept]
- taxuyunnanine U [MeSH Supplementary Concept]
- taxuyunnanine V [MeSH Supplementary Concept]
- tesetaxel [MeSH Supplementary Concept]
- wED protocol [MeSH Supplementary Concept]
- wallifoliol [MeSH Supplementary Concept]
- wallitaxane A [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
Validated automatic mappings to BTNT
- Taxane derivative (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients